<DOC>
	<DOC>NCT00882050</DOC>
	<brief_summary>The purpose of this project is to study if intravenous Exenatide is effective at maintaining normal blood glucose levels and preventing low blood glucose levels during surgery.</brief_summary>
	<brief_title>Intravenous Exenatide (Byetta) During Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Age (&gt;18 years) Weight of &gt; 50 kg and &lt; 150 kg Ability to provide informed consent Elective surgery including: Cardiac surgery to include elective CABG with or without single or multivalve repair or replacement and/or single or multivalve repair/replacement requiring CPB and sternotomy (to include subjects who are undergoing first time or redo cardiac surgery) Abdominal aortic aneurysm repair Carotid endarterectomy Esophagectomy Cystectomy Nephrectomy If female, subject must be nonlactating, and, if of childbearing potential, must have a negative urine pregnancy test within 24 hours prior to receiving study drug Age (&lt;18 years) Inability to provide informed consent History or risk of pancreatitis (e.g. ethanol abuse, gall stones) Receipt of an investigational drug or device with 30 days prior to surgery Use of any concomitant medication listed above on the day of surgery Known allergy to Exenatide, fentanyl, midazolam, isoflurane, propofol, heparin or neuromuscular blockers Known substance abuse Surgical procedure other than: Cardiac surgery to include elective CABG with or without single or multivalve repair or replacement and/or single or multivalve repair/ replacement requiring CPB and sternotomy (to include subjects who are undergoing first time or redo cardiac surgery) Abdominal aortic aneurysm repair Carotid endarterectomy Esophagectomy Cystectomy Nephrectomy Insulin dependent diabetes mellitis Anticipated administration of intraoperative steroids Major end organ dysfunction, defined as: Current intravenous inotropic agents Preoperative use of intraaortic balloon pump (IABP), left ventricular assist device (LVAD), or extracorporeal membrane oxygenation (ECMO) Renal Preoperative serum Creatinine &gt; 2.0 mg/dL Hepatic History of abnormal hepatic function in the past Hematologic Preoperative hematocrit (HCT) &lt; 30% Platelet count &lt; 100,000/mm3 History of bleeding or clotting disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>